NL-OMON26370尚未招募不适用
The ex-vivo potency of Edoxaban in patients with cirrhosis
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Age > 18 yrs
- •Child Pugh A or B cirrhosis
排除标准
- •Malignancies
- •Renal failure requiring intervention with drugs or dialysis
研究者
相似试验
已完成
3 期
The ex-vivo potency of Edoxaban in patients with cirrhosisNL-OMON45987niversitair Medisch Centrum Groningen16
进行中（未招募）
1 期
The interaction between the blood thinner edoxaban and the hormonal treatment tamoxifen in breast cancer patientsIf there are increased plasma levels of edoxaban when used concomitantly with the P-glycoproteïne inhibitor tamoxifen for the treatment of venous thromboembolism in patients with breast cancer.EUCTR2018-004450-24-NLTergooi Hospital, dep of internal medicine26
招募中
不适用
De wisselwerking tussen edoxaban en tamoxifen behandeling bij vrouwen met borstkankerPatients with oestrogen receptor positive breast cancer who are scheduled for adjuvant or palliative tamoxifen treatmentNL-OMON23145Daiichi Sankyo26
已完成
不适用
A pharmacokinetic study of edoxaban in patients with breast cancer using the P-glycoprotein inhibitor tamoxifevenous thromboembolismNL-OMON49411Tergooiziekenhuizen26
已完成
不适用
A study on efficacy and safety of Edoxaban on high-risk gastrointestinal endoscopic proceduresAll diseases that require high-risk gastrointestinal endoscopic procedures such as endoscopic polypectomy, endoscopic mucosal resection, endoscopic submucosal dissection or endoscopic mucosal ablationJPRN-UMIN000031523iigata University Graduate School of Medical and Dental Sciences12